Nuvilex, Inc. Names Two Significant Partners on Its Way to Phase 3 Clinical Trials
19 sept. 2013 09h00 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Sep 19, 2013) - Nuvilex, Inc. (OTCQB: NVLX) made another subtle but significant move this week that seems to signal the company is in "go-mode" on its future Phase III...
Nuvilex Contracts Fisher BioServices, Inc. for Long-Term Storage of Cells for Future Phase 3 Clinical Trials
10 sept. 2013 09h40 HE
|
Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Sep 10, 2013) - Nuvilex, Inc. (OTCQB: NVLX) (Company), an international biotechnology company providing cell and gene therapy solutions for the treatment of...